Kura Oncology, Inc.
KURA
$8.58
-$0.15-1.72%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -81.00M | -74.12M | -66.12M | -57.43M | -19.22M |
| Total Depreciation and Amortization | 403.00K | 164.00K | 224.00K | 241.00K | 204.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.07M | 9.18M | 4.57M | 5.31M | 5.89M |
| Change in Net Operating Assets | 187.80M | -15.86M | 32.55M | -20.05M | 282.26M |
| Cash from Operations | 117.27M | -80.63M | -28.78M | -71.93M | 269.13M |
| Capital Expenditure | -2.32M | -2.57M | -1.46M | -292.00K | -372.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -62.28M | 96.53M | 60.40M | -101.12M | -94.58M |
| Cash from Investing | -64.60M | 93.97M | 58.94M | -101.41M | -94.96M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.14M | 0.00 | 515.00K | 143.00K | 806.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.14M | 0.00 | 515.00K | 143.00K | 806.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 53.81M | 13.34M | 30.68M | -173.19M | 174.98M |